The Multiple Sclerosis Program at Cleveland Clinic Abu Dhabi’s Neurological Institute provides Patients First care for individuals with multiple sclerosis (MS). The Program is one of the largest and most comprehensive for MS in the region.
MS is an autoimmune condition that causes damage to the central nervous system. Our multidisciplinary team of caregivers offer expertise in a wide range of disciplines, including neurology, neuro-ophthalmology, rehabilitation medicine, physical therapy, speech therapy, occupational therapy, and urology.
The mission of all our team members is to work together with each patient and their family, to ensure an accurate and timely diagnosis, to provide a state-of-the-art treatment plan, and to support long-term management of the condition.
The Program offers FDA (United States Food & Drug Administration) approved disease modifying medications for MS patients, including intravenous medication that can be administered at the Cleveland Clinic Abu Dhabi Infusion Center.